Treatment of hereditary optic neuropathies
- 4 September 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Neurology
- Vol. 8 (10), 545-556
- https://doi.org/10.1038/nrneurol.2012.167
Abstract
The hereditary optic neuropathies are inherited disorders in which optic nerve dysfunction is a prominent feature in the phenotypic expression of disease. Optic neuropathy may be primarily an isolated finding, such as in Leber hereditary optic neuropathy and dominant optic atrophy, or part of a multisystem disorder. The pathophysiological mechanisms underlying the hereditary optic neuropathies involve mitochondrial dysfunction owing to mutations in mitochondrial or nuclear DNA that encodes proteins essential to mitochondrial function. Effective treatments are limited, and current management includes therapies directed at enhancing mitochondrial function and preventing oxidative damage, as well as genetic counselling, and supportive and symptomatic measures. New therapies, including gene therapy, are emerging via animal models and human clinical trials. Leber hereditary optic neuropathy, in particular, provides a unique model for testing promising treatments owing to its characteristic sequential bilateral involvement and the accessibility of target tissue within the eye. Lessons learned from treatment of the hereditary optic neuropathies may have therapeutic implications for other disorders of presumed mitochondrial dysfunction. In this Review, the natural history of the common inherited optic neuropathies, the presumed pathogenesis of several of these disorders, and the literature to date regarding potential therapies are summarized.Keywords
This publication has 114 references indexed in Scilit:
- Disorders of the Optic Nerve in Mitochondrial Cytopathies: New Ideas on Pathogenesis and Therapeutic TargetsCurrent Neurology and Neuroscience Reports, 2012
- The effects of idebenone on mitochondrial bioenergeticsBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2012
- Mitochondrial optic neuropathies – Disease mechanisms and therapeutic strategiesProgress in Retinal and Eye Research, 2011
- Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutationsEye, 2011
- Leber Hereditary Optic Neuropathy Gene Therapy Clinical Trial RecruitmentJAMA Ophthalmology, 2010
- The Neuro-ophthalmology of Mitochondrial DiseaseSurvey of Ophthalmology, 2010
- Mitochondrial Fusion Is Required for mtDNA Stability in Skeletal Muscle and Tolerance of mtDNA MutationsCell, 2010
- TMEM126A, Encoding a Mitochondrial Protein, Is Mutated in Autosomal-Recessive Nonsyndromic Optic AtrophyAmerican Journal of Human Genetics, 2009
- Optimized Allotopic Expression of the Human Mitochondrial ND4 Prevents Blindness in a Rat Model of Mitochondrial DysfunctionAmerican Journal of Human Genetics, 2008
- Outcomes of the Veterans Affairs Low Vision Intervention Trial (LOVIT)American Journal of Ophthalmology, 2008